Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Rashmi Sood PhD

Rashmi Sood PhD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Pathology
Division: Pediatric Pathology

Publications (34)

  • The endothelial protein C receptor plays an essential role in the maintenance of pregnancy. (Castillo MM, Yang Q, Sigala AS, McKinney DT, Zhan M, Chen KL, Jarzembowski JA, Sood R) Sci Adv 2020 Nov;6(45) PMID: 33158859 PMCID: PMC7673707 SCOPUS ID: 2-s2.0-85095802928 11/08/2020       5 Citations
  • The Endothelial Protein C Receptor plays an essential role in the maintenance of Pregnancy (Castillo MM, Yang Q, Sigala AS, McKinney DT, Zhan M, Chen KL, Jarzembowski JA, Sood R) BioRxiv https://doi.org/10.1101/2020.02.05.935940 02/05/2020    
  • Deficiency of Protease Activated Receptor 3 in the Mother Prevents Placenta-Mediated Death of Endothelial Protein C Receptor Null Mice, but Uncovers an Obligate Requirement of EPCR in the Embryo and Neonate. (Castillo MM, Yang Q, Sood R) Blood 134 (Supplement_1): 2382; https://doi.org/10.1182/blood-2019-131453 11/13/2019    
  • Genetic Absence of Integrin alpha2b Improves Survival of Tissue Factor Pathway Inhibitor Null Mice but Results in Hydrocephalus Formation (Castillo M, Ott E, Wujek R, Qiuli L, Schmainda K, Cohen S, Sood R) Blood 134 (Supplement_1): 3626; https://doi.org/10.1182/blood-2019-131811 11/13/2019    
  • Animal Models Demonstrate a Critical Role of Factor VIII in Par4-and Platelet-Mediated Pathology (Castillo M, Yang Q, McKinney D, Shi Q, Sood R) Blood 134 (Supplement_1): 1057; https://doi.org/10.1182/blood-2019-123290 11/13/2019    
  • Maintaining extraembryonic expression allows generation of mice with severe tissue factor pathway inhibitor deficiency. (Castillo MM, Yang Q, Zhan M, Pan AY, Lawlor MW, Mast AE, Sood R) Blood Adv 2019 Feb 12;3(3):489-498 PMID: 30755437 PMCID: PMC6373739 SCOPUS ID: 2-s2.0-85061474836 02/14/2019       9 Citations
  • Humanized GPIbα-von Willebrand factor interaction in the mouse. (Kanaji S, Orje JN, Kanaji T, Kamikubo Y, Morodomi Y, Chen Y, Zarpellon A, Eberhardt J, Forli S, Fahs SA, Sood R, Haberichter SL, Montgomery RR, Ruggeri ZM) Blood Adv 2018 Oct 09;2(19):2522-2532 PMID: 30287479 PMCID: PMC6177644 SCOPUS ID: 2-s2.0-85069786057 10/06/2018       13 Citations
  • Variable phenotypic penetrance of thrombosis in adult mice after tissue-selective and temporally controlled Thbd gene inactivation. (van Mens TE, Liang HH, Basu S, Hernandez I, Zogg M, May J, Zhan M, Yang Q, Foeckler J, Kalloway S, Sood R, Karlson CS, Weiler H) Blood Adv 2017 Jun 27;1(15):1148-1158 PMID: 28920104 PMCID: PMC5600150 SCOPUS ID: 2-s2.0-85050503897 09/19/2017       16 Citations
  • Absence of platelet thrombin receptor PAR4 prevents thrombotic and stroke-like phenotypes of thrombomodulin deficient mice (Storage M, Yang Q, Zhan M, Sood R) Res Pract Thromb Haemost 1 (S1): 87; OC 02.5; https://doi.org/10.1002/rth2.12012 06/23/2017    
  • Maintaining extraembryonic expression allows generation of adult mice with Tissue Factor Pathway Inhibitor gene disruption (Storage M, Yang Q, Zhan M, Sood R) Res Pract Thromb Haemost 1 (S1): 86; OC 02.1; https://doi.org/10.1002/rth2.12012 06/23/2017    
  • Vasculogenesis and Angiogenesis (Chun CZ, Sood R, Ramchandran R) In: North P., Sander T. (eds) Vascular Tumors and Developmental Malformations. Molecular and Translational Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3240-5_3 01/01/2016    
  • Genetic Absence of Thrombin Receptor Par4 Overcomes the Obligate Requirement of EPCR in Mouse Placenta (Storage MM, An J, Liang H, Yang Q, Zogg M, Zhan M, Weiler H, Sood R) Blood 126 (23): 425; https://doi.org/10.1182/blood.V126.23.425.425 12/03/2015    
  • An Experimental Model of Platelet Activation at the Feto-Maternal Interface (Arumugam V, An J, Bordas M, Sood R) Blood 124 (21): 2766; https://doi.org/10.1182/blood.V124.21.2766.2766 12/06/2014    
  • Heparin rescues factor V Leiden-associated placental failure independent of anticoagulation in a murine high-risk pregnancy model. (An J, Waitara MS, Bordas M, Arumugam V, Hoffmann RG, Petrich BG, Sinha U, North PE, Sood R) Blood 2013 Mar 14;121(11):2127-34 PMID: 23325830 PMCID: PMC3952382 SCOPUS ID: 2-s2.0-84877593502 01/18/2013       17 Citations
  • Thrombin activation of maternal platelets causes placental developmental failure through a mechanism independent of thrombosis in a murine high-risk pregnancy model (Arumugam V, An J, Bordas M, Sood R) Placenta 9 (34): A83; P2.79; https://doi.org/10.1016/j.placenta.2013.06.245 01/01/2013    
  • IFPA Meeting 2012 Workshop Report III: trophoblast deportation, gestational trophoblastic disease, placental insufficiency and fetal growth restriction, trophoblast over-invasion and accreta-related pathologies, placental thrombosis and fibrinolysis. (Al-Khan A, Bulmer JN, Chantraine F, Chen CP, Chen Q, Collins S, Cotechini T, Fitzgerald JS, He M, Holland O, Hung TH, Illsley NP, Ino K, Iwaki T, Kanayama N, Kaneki E, Katabuchi H, Kobayashi Y, Kondo A, Masuzaki H, Matjila M, Miura K, Mori A, Murthi P, Nagahashi K, Nie G, Ohba T, Sood R, Sugimura M, Takizawa T, Usui H, Velicky P, Lash GE) Placenta 2013 Mar;34 Suppl:S11-6 PMID: 23257209 SCOPUS ID: 2-s2.0-84884213974 12/22/2012       10 Citations
  • Thrombophilia and fetal loss: Lessons from gene targeting in mice. (Sood R) Thromb Res 2009;123 Suppl 2:S79-84 PMID: 19217483 SCOPUS ID: 2-s2.0-65549169814 02/17/2009       7 Citations
  • Caveolin-1-dependent apoptosis induced by fibrin degradation products. (Guo YH, Hernandez I, Isermann B, Kang TB, Medved L, Sood R, Kerschen EJ, Holyst T, Mosesson MW, Weiler H) Blood 2009 Apr 30;113(18):4431-9 PMID: 19074731 PMCID: PMC2676096 SCOPUS ID: 2-s2.0-66149083175 12/17/2008       36 Citations
  • Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin. (Sood R, Sholl L, Isermann B, Zogg M, Coughlin SR, Weiler H) Blood 2008 Aug 01;112(3):585-91 PMID: 18490515 PMCID: PMC2481555 SCOPUS ID: 2-s2.0-50949133923 05/21/2008       36 Citations
  • Combined tissue factor pathway inhibitor and thrombomodulin deficiency produces an augmented hypercoagulable state with tissue-specific fibrin deposition. (Maroney SA, Cooley BC, Sood R, Weiler H, Mast AE) J Thromb Haemost 2008 Jan;6(1):111-7 PMID: 17973652 PMCID: PMC3646640 SCOPUS ID: 2-s2.0-37548998987 11/02/2007       29 Citations
  • Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. (Kerschen EJ, Fernandez JA, Cooley BC, Yang XV, Sood R, Mosnier LO, Castellino FJ, Mackman N, Griffin JH, Weiler H) J Exp Med 2007 Oct 01;204(10):2439-48 PMID: 17893198 PMCID: PMC2118455 SCOPUS ID: 2-s2.0-34948866150 09/26/2007       270 Citations
  • Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers. (Sood R, Zogg M, Westrick RJ, Guo YH, Kerschen EJ, Girardi G, Salmon JE, Coughlin SR, Weiler H) J Exp Med 2007 May 14;204(5):1049-56 PMID: 17438064 PMCID: PMC2118565 SCOPUS ID: 2-s2.0-34249051898 04/18/2007       36 Citations
  • Endothelial mimicry of placental trophoblast cells (Weiler H, Sood R) Endothelial Biomedicine 1 January 2007:1479-1487 SCOPUS ID: 2-s2.0-67649461784 01/01/2007       1 Citation
  • Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. (Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H) Blood 2006 Apr 15;107(8):3173-80 PMID: 16380449 PMCID: PMC1895751 SCOPUS ID: 2-s2.0-33645746632 12/29/2005       89 Citations
  • A critical role of Platelets and the Par4 receptor in developmental growth arrest of thrombomodulin null embryos (Sood R, Zogg M, Weiler H) Blood 106 (11): 529; https://doi.org/10.1182/blood.V106.11.529.529 11/16/2005    
  • Thrombophilia and pregnancy failure: feto-maternal interactions in the vascular bed of the placenta. (Sood R, Kalloway S, Mast AE, Weiler H) Thromb Res 2005 Feb;115 Suppl 1:92-4 PMID: 15790167 SCOPUS ID: 2-s2.0-12544257871 03/26/2005       2 Citations
  • Cause-effect relation between hyperfibrinogenemia and vascular disease. (Kerlin B, Cooley BC, Isermann BH, Hernandez I, Sood R, Zogg M, Hendrickson SB, Mosesson MW, Lord S, Weiler H) Blood 2004 Mar 01;103(5):1728-34 PMID: 14615369 SCOPUS ID: 2-s2.0-10744231546 11/15/2003       85 Citations
  • Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia. (Kerlin BA, Yan SB, Isermann BH, Brandt JT, Sood R, Basson BR, Joyce DE, Weiler H, Dhainaut JF) Blood 2003 Nov 01;102(9):3085-92 PMID: 12869495 SCOPUS ID: 2-s2.0-0142245617 07/19/2003       142 Citations
  • Embryogenesis and gene targeting of coagulation factors in mice. (Sood R, Weiler H) Best Pract Res Clin Haematol 2003 Jun;16(2):169-81 PMID: 12763485 SCOPUS ID: 2-s2.0-0038656542 05/24/2003       6 Citations
  • The thrombomodulin-protein C system is essential for the maintenance of pregnancy. (Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen JL, Mackman N, Weiler H) Nat Med 2003 Mar;9(3):331-7 PMID: 12579195 SCOPUS ID: 2-s2.0-0037349926 02/13/2003       232 Citations
  • Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. (Chakrabarti SR, Sood R, Nandi S, Nucifora G) Proc Natl Acad Sci U S A 2000 Nov 21;97(24):13281-5 PMID: 11078523 PMCID: PMC27216 SCOPUS ID: 2-s2.0-0034700082 11/15/2000       104 Citations
  • Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements. (Sitailo S, Sood R, Barton K, Nucifora G) Leukemia 1999 Nov;13(11):1639-45 PMID: 10557037 SCOPUS ID: 2-s2.0-0032723317 11/11/1999       65 Citations
  • Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9. (Chakrabarti SR, Sood R, Ganguly S, Bohlander S, Shen Z, Nucifora G) Proc Natl Acad Sci U S A 1999 Jun 22;96(13):7467-72 PMID: 10377438 PMCID: PMC22109 SCOPUS ID: 2-s2.0-0033594979 06/23/1999       75 Citations
  • MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1. (Sood R, Talwar-Trikha A, Chakrabarti SR, Nucifora G) Leukemia 1999 Mar;13(3):348-57 PMID: 10086725 SCOPUS ID: 2-s2.0-0033014867 03/23/1999       108 Citations
    • Last update: 03/17/2022